ClinicalTrials.Veeva

Menu

Resting Energy Expenditure Evaluation in Subjects With Crohn's Disease (REECD)

F

Fabrizio Pasanisi

Status

Unknown

Conditions

Crohn Disease

Treatments

Other: Indirect Calorimetry

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this study is to investigate the effect disease activity on resting energy expenditure (REE), body composition, inflammatory markers, food intake and quality of life in subjects affected by Crohn's Disease (CD)

Full description

Malnutrition is a common sequel among patients affected by Crohn's disease (CD). The pathogenic mechanisms include poor dietary intake, increased resting energy expenditure (REE), nutrient malabsorption and loss. So far, few studies have been carried out in CD adult patients, assessing the effect of disease activity on both REE and body composition. Vaisman et al (2006) studied sixteen CD patients in remission (> 3 mo) and showed no effect of REE on lower BMI, although in the presence of similar energy intake in according with previous studies (Al-Jaouni et al., 2000; Schneeweiss et al., 1999). While, Gong et al., 2015 found that patients with active disease had an increase in REE compared to patients in remission as already shown by Rigaud et al., 1993; Kushner and Schoeller, 1991. Overall, the effect of disease activity on REE is still uncertain and requires further investigation.

Enrollment

150 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of Crohn's Disease

Exclusion criteria

  • Comorbidity affecting energy metabolism (diabetes mellitus, thyroid dysfunction, etc.)
  • History of acute or chronic liver or kidney disease
  • Current parenteral nutrition
  • Presence of fistulae, ileostomy or colostomy
  • Presence of extensive small bowel resection (residual small bowel < 2 meters)
  • Pregnancy or lactation

Trial design

150 participants in 1 patient group

Subject-CD
Description:
Subjects with Crohn's Disease in active or quiescent phase, classified according to Crohn's Disease Activity Index (CDAI \>150 active; CDAI \< 150 quiescent)
Treatment:
Other: Indirect Calorimetry

Trial contacts and locations

1

Loading...

Central trial contact

Fabrizio Pasanisi, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems